Citation: Mr. Somerfield et La. Fogarty, Commentary on Siegel and Schrimshaw's 'Coping with negative emotions: The cognitive strategies of HIV-infected gay/bisexual men', J HEAL PSYC, 6(1), 2001, pp. 121-124
Authors:
Bast, RC
Ravdin, P
Hayes, DF
Bates, S
Fritsche, H
Jessup, JM
Kemeny, N
Locker, GY
Mennel, RG
Somerfield, MR
Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(6), 2001, pp. 1865-1878
Authors:
Bast, RC
Ravdin, P
Hayes, DF
Bates, S
Fritsche, H
Jessup, JM
Kemeny, N
Locker, GY
Mennel, RG
Somerfield, MR
Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markets in breast and colorectal cancer: Clinical practice guidelines for the American Society ofClinical Oncology (vol 19, pg 1865, 2001), J CL ONCOL, 19(21), 2001, pp. 4185-4188
Authors:
Ozer, H
Armitage, JO
Bennett, CL
Crawford, J
Demetri, GD
Pizzo, PA
Schiffer, CA
Smith, TJ
Somlo, G
Wade, JC
Wade, JL
Winn, RJ
Wozniak, AJ
Somerfield, MR
Citation: H. Ozer et al., 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines, J CL ONCOL, 18(20), 2000, pp. 3558-3585
Authors:
Benson, AB
Desch, CE
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Smith, TJ
Somerfield, MR
Citation: Ab. Benson et al., 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines, J CL ONCOL, 18(20), 2000, pp. 3586-3588
Citation: Mr. Somerfield et Rr. Mccrae, Stress and coping research - Methodological challenges, theoretical advances, and clinical applications, AM PSYCHOL, 55(6), 2000, pp. 620-625
Citation: Cl. Bennett et al., The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey, ANN ONCOL, 10(11), 1999, pp. 1355-1359
Authors:
Chlebowski, RT
Collyar, DE
Somerfield, MR
Pfister, DG
Citation: Rt. Chlebowski et al., American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene, J CL ONCOL, 17(6), 1999, pp. 1939-1955
Authors:
Desch, CE
Benson, AB
Smith, TJ
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Somerfield, MR
Citation: Ce. Desch et al., Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology, J CL ONCOL, 17(4), 1999, pp. 1312-1321
Authors:
Smith, TJ
Davidson, NE
Schapira, DV
Grunfeld, E
Muss, HB
Vogel, VG
Somerfield, MR
Citation: Tj. Smith et al., American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines, J CL ONCOL, 17(3), 1999, pp. 1080-1082
Citation: Cl. Bennett et al., Use of hematopoietic colony-stimulating factors: Comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines, J CL ONCOL, 17(11), 1999, pp. 3676-3681
Citation: Cl. Bennett et Mr. Somerfield, Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors - In reply, J CL ONCOL, 17(10), 1999, pp. 3361-3361